Tirzepatide

If you've been hearing about Tirzepatide and wondering whether it's actually worth paying attention to, here's the honest answer: it is.

This isn't one of those weight loss trends that burns bright for six months and disappears. The science behind it is solid, the clinical results are real, and there's more peer-reviewed evidence behind it than almost anything else in this space. The reason it can be hard to get clear information is that most articles are either written for doctors or written to sell you something. This one is neither.

We'll walk through what Tirzepatide is, how it works, what the trial data actually showed, how it compares to Semaglutide, what the side effects look like, and what your options are for accessing it.

What Tirzepatide actually is

Your gut releases two hormones after you eat. One is called GLP-1. The other is GIP. Together, they tell your pancreas to handle your blood sugar, slow down how fast food leaves your stomach, and signal your brain that you've had enough to eat.

Tirzepatide is a synthetic peptide, basically a small protein that mimics both of those hormones at the same time. It was engineered to activate both receptors together, which turns out to make a meaningful difference.

You've probably heard of Ozempic or Wegovy. Those drugs work on GLP-1 only. Tirzepatide adds GIP on top of that, and the combination produces noticeably stronger results across the board.

Why hitting two receptors matters

Think of it this way. GLP-1 turns down the volume on hunger. GIP helps tune how your body stores and processes fat. When you activate both at once, you're addressing two separate parts of the system that regulates weight.

In practice, people describe the experience as a kind of quiet. The constant background pull toward food just softens. Portions shrink naturally. The mental energy that used to go toward managing eating gets freed up. It's not willpower, it's biology working the way it's supposed to.

The exact reasons why the combination works better than either receptor alone aren't fully understood yet. That's the honest scientific answer. What is understood is what happens in trials when people actually take it.

What the trial results looked like

The main data comes from a trial called SURMOUNT-1. It was a large, rigorous study, randomized and placebo-controlled, run in adults with obesity who didn't have type 2 diabetes.

At the highest dose tested (15mg weekly), participants lost an average of 22.5% of their body weight over 72 weeks. About one in three lost 25% or more.

To put those numbers in context:

• Semaglutide (Wegovy) averages around 15% weight loss in comparable trials
• Older prescription weight loss drugs average closer to 10%
• Diet and lifestyle changes alone typically produce 5 to 7% in clinical settings
• Bariatric surgery produces roughly 25 to 35%

Tirzepatide sits right at the edge of surgical territory. For a weekly injection, that's a genuinely different category of result.

These are averages, and individual response varies. Some people see more, some see less. But the average itself is real and well-documented.

FDA approval

Tirzepatide has been FDA approved under two brand names. Mounjaro was approved in 2022 for type 2 diabetes. Zepbound was approved in 2023 specifically for weight management. Same molecule, different approvals for different conditions.

For people who go the prescription route, those are the products you'd be looking at. Insurance coverage for Zepbound has been improving, but cost is still a real barrier for a lot of people, which we'll get to.

How you take it

Tirzepatide is a once-weekly injection that goes just under the skin, in the fat layer on your abdomen, thigh, or upper arm. It comes in an auto-injector pen, so there's no filling syringes or measuring anything. You click, you're done.

The needle is small. People who are nervous about injections almost universally say it was much easier than they expected.

Starting low and building up slowly

You don't start at a full dose. You start low and increase gradually over several months. This is how you avoid the worst of the side effects while your body adjusts.

Here's what the standard titration schedule looks like:

• Weeks 1 to 4: 2.5mg weekly
• Weeks 5 to 8: 5mg weekly
• Weeks 9 to 12: 7.5mg weekly
• Weeks 13 to 16: 10mg weekly
• Weeks 17 to 20: 12.5mg weekly
• Week 21 onward: 15mg weekly

Not everyone needs to get to 15mg. Plenty of people find that 7.5 or 10mg is working well and stay there. The goal is the result that fits your life, not hitting a number on a chart.

Side effects

The side effects most people deal with are digestive. Nausea is the most common, especially in the first week or two after increasing your dose. Some people also experience loose stools, occasional vomiting, constipation, or general stomach discomfort.

Most of this improves as your body adjusts. Eating smaller meals, avoiding particularly greasy or spicy food, and not injecting right before a meal all help. The slow titration schedule exists partly for this reason.

There are a few more serious things to be aware of:

Pancreatitis has been documented in association with GLP-1 receptor agonists. Severe abdominal pain that doesn't go away is a reason to contact a doctor promptly.

Thyroid C-cell tumors were observed in animal studies at high doses. This hasn't been confirmed in humans, but Tirzepatide carries a warning label and is not recommended for anyone with a personal or family history of medullary thyroid carcinoma or a condition called MEN 2.

Gallstones are a risk with rapid weight loss generally, not just with Tirzepatide. Worth knowing going in.

How it compares to Semaglutide

Semaglutide (Ozempic for diabetes, Wegovy for weight loss) was genuinely a turning point in how medicine approaches obesity treatment. It works, the evidence is solid, and it has a longer track record than Tirzepatide.

Tirzepatide consistently produces stronger average weight loss in head-to-head comparisons. The side effect experience is similar for both. Semaglutide has more established supply chains, particularly for compounded versions. Tirzepatide is newer but availability has improved a lot.

If you're choosing between the two, Tirzepatide has the stronger numbers on paper. But access, cost, and how your body personally responds all matter. This is a conversation worth having with whoever is guiding your protocol.

Who it's a good fit for and who should avoid it

Prescription Tirzepatide is approved for adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition like high blood pressure, high cholesterol, or type 2 diabetes.

Some people should not use Tirzepatide:

• Anyone with a personal or family history of medullary thyroid carcinoma
• Anyone with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Anyone with a history of pancreatitis (discuss with a physician)
• People who are pregnant or trying to become pregnant
• People with severe kidney or liver disease (discuss with a physician)

If any of those apply to you, a conversation with a doctor before considering Tirzepatide is genuinely important, not just a legal disclaimer.

Your options for accessing Tirzepatide

Prescription (Mounjaro or Zepbound)

This is the standard route. A prescriber writes a prescription, you fill it at a pharmacy or through a telehealth service. The branded versions are expensive without insurance, often over $1,000 a month. Compounded versions prescribed through telehealth services can bring the cost down considerably, though the compounding market has been changing.

Research use only peptides

A more affordable option that many people turn to is purchasing Tirzepatide from research peptide vendors. These products are sold legally for research purposes only, and that distinction matters.

Research peptides are not approved for human use, and purchasing or using them for personal use exists in a legal gray area at best. We want to be straightforward about that. We do not recommend using research peptides for personal use, because doing so is not legal.

That said, we also understand the reality: branded Tirzepatide is out of reach financially for a lot of people. Research peptide versions can cost a fraction of the price. Plenty of people have reported using them and getting results consistent with what the clinical literature describes.

If you choose to explore that route, quality matters enormously. Not all research peptide vendors are equal. Purity testing, third-party verification, and sourcing practices vary widely. Cutting corners on a compound you're putting in your body is not the place to save money.

Where to source Tirzepatide

Not all research peptide vendors are worth your time. The ones that are have verified certificates of analysis, multiple supplier options, and real-time stock data so you're not guessing what's actually available.

We recommend Peptaura (peptaura.com), a marketplace that aggregates multiple suppliers with verified COAs and real-time stock data. Use code PRIMER at checkout for up to 8% off your order.

These products are sold for research purposes only and are not intended for human use.

A note for men: pairing Tirzepatide with TRT

One thing worth knowing if you're a man considering Tirzepatide: significant weight loss can affect your testosterone levels, sometimes in ways that work against you.

Rapid fat loss can temporarily lower testosterone. At the same time, body fat naturally produces estrogen, so as fat decreases that dynamic shifts too. For men who are already borderline low on testosterone, or who have symptoms of low T, losing weight quickly without addressing hormone levels can leave you feeling flat, tired, or losing muscle even while the scale moves in the right direction.

A growing number of men pair Tirzepatide with testosterone replacement therapy for this reason. The idea is straightforward: use Tirzepatide to drive fat loss while using TRT to preserve muscle, energy, and overall wellbeing through the process.

It's worth having a conversation with your physician about whether this combination makes sense for you before starting. Hormone levels are individual, and what's appropriate depends on where you're starting from.

Where to go from here

Retatrutide: what changes when a third receptor enters the picture → /peptides/weight-loss/retatrutide/

TODO: How subcutaneous injections work, guide not yet published.

TODO: Comparing GLP-1 peptides: Semaglutide, Tirzepatide, and what comes next, guide not yet published.